Gastroenterology - European Medical Journal

Continue

Gastroenterology

Filter
10 Oct 2017

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Tel-Aviv, Israel/Raleigh, NC, USA, 03 October, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“Red Hill” or the “Company”)…
3 Oct 2017

Studying Protein Networks in Bowel Cancer

PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response….
3 Oct 2017

Role of Gut Bacteria as a Parkinson’s Disease Biomarker

BACTERIAL communities in the gut of Parkinson’s patients differ to those of healthy people, potentially providing an early indicator of the…
19 Sep 2017

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.

RedHill Biopharma Ltd. announced that it has initiated promotion of Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg1 in the U.S.
28 Jul 2017

Why the Doctors’ Mantra Is Killing Them

It’s a deadly secret that many of us keep inside. It’s a burden that only we can feel, while acting completely unaffected to the outside world.
18 Jul 2017

RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D

Tel-Aviv, Israel / Raleigh, NC, USA, 17 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…
12 Jul 2017

RedHill Biopharma Announces Expected Timeline for DSMB Meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

Tel-Aviv, Israel / Raleigh, NC, USA, 12 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…
3 Jul 2017

Key to Preventing Listeriosis Found in Gut Microbiome

BACTERIA discovered in the gut could prove invaluable for preventing Listeria infection, according to a new study from researchers at the Memorial Sloan…